KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Current Leases (2016 - 2025)

Neogenomics' Current Leases history spans 16 years, with the latest figure at $4.8 million for Q4 2025.

  • For Q4 2025, Current Leases rose 41.26% year-over-year to $4.8 million; the TTM value through Dec 2025 reached $4.8 million, up 41.26%, while the annual FY2025 figure was $4.8 million, 41.26% up from the prior year.
  • Current Leases reached $4.8 million in Q4 2025 per NEO's latest filing, up from $4.5 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $6.9 million in Q1 2023 to a low of $11000.0 in Q2 2023.
  • Average Current Leases over 5 years is $4.0 million, with a median of $4.3 million recorded in 2024.
  • Peak YoY movement for Current Leases: tumbled 97.32% in 2023, then skyrocketed 32390.91% in 2024.
  • A 5-year view of Current Leases shows it stood at $6.9 million in 2021, then dropped by 4.36% to $6.6 million in 2022, then fell by 14.79% to $5.6 million in 2023, then plummeted by 39.73% to $3.4 million in 2024, then skyrocketed by 41.26% to $4.8 million in 2025.
  • Per Business Quant, the three most recent readings for NEO's Current Leases are $4.8 million (Q4 2025), $4.5 million (Q3 2025), and $4.1 million (Q2 2025).